Literature DB >> 1833467

A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.

J Freysdottir1, A Sigfusson.   

Abstract

A flow cytometric assay (FCA) was developed to measure complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes. It was possible to measure these parameters accurately with intra- and interassay coefficients of variation of 2.0% and 6.5% respectively. The method was able to discriminate between low and high levels of erythrocyte CR1, C3d and C4d. Comparison with a previously described RIA method gave excellent correlation coefficients with r2 values of 0.94, 0.93 and 0.91 for CR1, C3d and C4d respectively. The flow cytometric assay was used to measure CR1, C3d and C4d on the erythrocytes of 98 healthy individuals and the 95% upper limits for C3d and C4d were established. There was a wide distribution of CR1 levels amongst these individuals but their C3d and C4d levels were low and often not above background. The possible application of this method in clinical medicine is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833467     DOI: 10.1016/0022-1759(91)90291-m

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.

Authors:  J Freysdottir; S Ormarsdottir; A Sigfusson
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

2.  Effect of Haimiding on the functioning of red cell membrane of FC and H22 tumor-bearing mice.

Authors:  Yu-Bin Ji; Shi-Yong Gao; Wei-Ping Cheng
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

Review 3.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

Review 4.  Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  John Hulme
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

5.  Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.

Authors:  Paola Adele Lonati; Mariangela Scavone; Maria Gerosa; Maria Orietta Borghi; Francesca Pregnolato; Daniele Curreli; Gianmarco Podda; Eti Alessandra Femia; Wilma Barcellini; Marco Cattaneo; Francesco Tedesco; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.